A Nomogram for Predicting In-Stent Restenosis Risk in Patients Undergoing Percutaneous Coronary Intervention: A Population-Based Analysis

References

• Khattab MH, Sherry AD, Barker CM. The birth, decline, and contemporary re-emergence of endovascular brachytherapy for prevention of in-stent restenosis. Brachytherapy. 2021;20(2):485–493. doi:10.1016/j.brachy.2020.09.012
   PubMed Web of Science ®Google Scholar
• Singh AD, Singal AK, Mian A, et al. Recurrent Drug-Eluting Stent In-Stent Restenosis: a State-of-the-Art Review of Pathophysiology, Diagnosis, and Management. Cardiovasc Revasc Med. 2020;21(9):1157–1163. doi:10.1016/j.carrev.2020.01.005
   PubMed Web of Science ®Google Scholar
• Lee MS, Banka G. In-stent Restenosis. Interv Cardiol Clin. 2016;5(2):211–220. doi:10.1016/j.iccl.2015.12.006
   PubMedGoogle Scholar
• Bakogiannis C, Sachse M, Stamatelopoulos K, et al. Platelet-derived chemokines in inflammation and atherosclerosis. Cytokine. 2019;122:154157. doi:10.1016/j.cyto.2017.09.013
   PubMed Web of Science ®Google Scholar
• Gai M-T, Zhu B, Chen X-C, et al. A prediction model based on platelet parameters, lipid levels, and angiographic characteristics to predict in-stent restenosis in coronary artery disease patients implanted with drug-eluting stents. Lipids Health Dis. 2021;20(1):118. doi:10.1186/s12944-021-01553-2
   PubMed Web of Science ®Google Scholar
• He W, Xu C, Wang X, et al. Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention. BMC Cardiovasc Disord. 2021;21(1):435. doi:10.1186/s12872-021-02255-4
   PubMed Web of Science ®Google Scholar
• Lorenzatti AJ, Toth PP. New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease. Eur Cardiol. 2020;15:1–9. doi:10.15420/ecr.2019.06
   PubMed Web of Science ®Google Scholar
• Stolker JM, Kennedy KF, Lindsey JB, et al. Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry. Circ Cardiovasc Interv. 2010;3(4):327–334. doi:10.1161/CIRCINTERVENTIONS.110.946939
   PubMed Web of Science ®Google Scholar
• Almagro P, Boixeda R, Diez-Manglano J, et al. Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease. Int J Chron Obstruct Pulmon Dis. 2020;15:755–764. doi:10.2147/COPD.S238214
   PubMed Web of Science ®Google Scholar
• Liu Y, Imanishi T, Ikejima H, et al. Association between circulating monocyte subsets and in-stent restenosis after coronary stent implantation in patients with ST-elevation myocardial infarction. Circ J. 2010;74(12):2585–2591. doi:10.1253/circj.CJ-10-0544
   PubMed Web of Science ®Google Scholar
• Nan J, Meng S, Hu H, et al. The Predictive Value of Monocyte Count to High-Density Lipoprotein Cholesterol Ratio in Restenosis After Drug-Eluting Stent Implantation. Int J Gen Med. 2020;13:1255–1263. doi:10.2147/IJGM.S275202
   PubMed Web of Science ®Google Scholar
• Afari ME, Bhat T. Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. Expert Rev Cardiovasc Ther. 2016;14(5):573–577. doi:10.1586/14779072.2016.1154788
   PubMed Web of Science ®Google Scholar
• Yang Y, Ge F, Shen J, et al. The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery. Biosci Rep. 2020;40:7. doi:10.1042/BSR20193448
   Web of Science ®Google Scholar
• Castañer O, Pintó X, Subirana I, et al. Remnant Cholesterol, Not LDL Cholesterol, Is Associated With Incident Cardiovascular Disease. J Am Coll Cardiol. 2020;76(23):2712–2724. doi:10.1016/j.jacc.2020.10.008
   PubMed Web of Science ®Google Scholar
• Varbo A, Nordestgaard BG. Remnant lipoproteins. Curr Opin Lipidol. 2017;28(4):300–307. doi:10.1097/MOL.0000000000000429
   PubMed Web of Science ®Google Scholar
• Rampidis GP, Benetos G, Benz DC, et al. A guide for Gensini Score calculation. Atherosclerosis. 2019;287:181–183. doi:10.1016/j.atherosclerosis.2019.05.012
   PubMed Web of Science ®Google Scholar
• Hayıroğlu M, Çınar T, Çinier G, et al. Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction. Pacing Clin Electrophysiol. 2022;45(2):188–195. doi:10.1111/pace.14436
   PubMed Web of Science ®Google Scholar
• Cakir Guney B, Hayiroglu M, Senocak D, et al. Evaluation of N/LP Ratio as a Predictor of Disease Progression and Mortality in COVID-19 Patients Admitted to the Intensive Care Unit. Medeni Med J. 2021;36(3):241–248. doi:10.5222/MMJ.2021.95676
   PubMedGoogle Scholar
• Balta S, Celik T, Mikhailidis DP, et al. The Relation Between Atherosclerosis and the Neutrophil-Lymphocyte Ratio. Clin Appl Thromb Hemost. 2016;22(5):405–411. doi:10.1177/1076029615569568
   PubMed Web of Science ®Google Scholar
• Shen H, Dai Z, Wang M, et al. Preprocedural Neutrophil to Albumin Ratio Predicts In-Stent Restenosis Following Carotid Angioplasty and Stenting. J Stroke Cerebrovasc Dis. 2019;28(9):2442–2447. doi:10.1016/j.jstrokecerebrovasdis.2019.06.027
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu C, Fang H. Blood Cell Parameters and Predicting Coronary In-Stent Restenosis. Angiology. 2019;70(8):711–718. doi:10.1177/0003319719830495
   PubMed Web of Science ®Google Scholar
• Zhu G, Li Z, Yuan L, et al. The Relationship Between Neutrophil-Lymphocyte Ratio and In-Stent Restenosis. Angiology. 2018;69(7):642–643. doi:10.1177/0003319718762913
   PubMed Web of Science ®Google Scholar
• Li B, Wang A, Wang Y, et al. A study on the correlation between remnant cholesterol and urinary albumin to creatinine ratio in Chinese community adults: a report from the REACTION study. J Diabetes. 2020;12(12):870–880. doi:10.1111/1753-0407.13076
   PubMed Web of Science ®Google Scholar
• Maranhão RC, Pala D, Freitas FR. Lipoprotein removal mechanisms and aging: implications for the cardiovascular health of the elderly. Curr Opin Endocrinol Diabetes Obes. 2020;27(2):104–109. doi:10.1097/MED.0000000000000529
   PubMedGoogle Scholar
• Januszek R, Siudak Z, Dziewierz A, et al. Chronic obstructive pulmonary disease affects the angiographic presentation and outcomes of patients with coronary artery disease treated with percutaneous coronary interventions. Pol Arch Intern Med. 2018;128(1):24–34. doi:10.20452/pamw.4145
   PubMedGoogle Scholar
• Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999;99(1):44–52. doi:10.1161/01.CIR.99.1.44
   PubMed Web of Science ®Google Scholar
• Onishi K. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease. J Cardiol. 2017;70(2):128–134. doi:10.1016/j.jjcc.2017.03.001
   PubMed Web of Science ®Google Scholar
• Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010;65(10):930–936. doi:10.1136/thx.2009.130260
   PubMed Web of Science ®Google Scholar
• Stolker JM, Cohen DJ, Kennedy KF, et al. Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement. Cardiovasc Revasc Med. 2017;18(3):169–176. doi:10.1016/j.carrev.2016.12.014
   PubMed Web of Science ®Google Scholar
• Yeh RW, Normand S-LT, Wolf RE, et al. Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention. Circulation. 2011;124(14):1557–1564. doi:10.1161/CIRCULATIONAHA.111.045229
   PubMed Web of Science ®Google Scholar
• Avci A, Fidan S, Tabakçı MM, et al. Association between the Gensini Score and Carotid Artery Stenosis. Korean Circ J. 2016;46(5):639–645. doi:10.4070/kcj.2016.46.5.639
   PubMed Web of Science ®Google Scholar
• Morice MC. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation. 2010;121(24):2645–2653. doi:10.1161/CIRCULATIONAHA.109.899211
   PubMed Web of Science ®Google Scholar